-
Carboplatin Resistance: A DNA Damage Assay Guide
2026-09-17
Carboplatin is a platinum-based DNA synthesis inhibitor used to connect DNA damage, cancer stemness, and treatment resistance. This guide translates recent TNBC findings into practical assay and combination-study decisions for preclinical oncology research.
-
Myriocin, HIF-1, and Ferroptosis Protection
2026-09-17
The reference study identifies HIF-1 activation as a mechanistic explanation for how myriocin protects HT22 neuronal cells from erastin- or glutamate-induced ferroptosis without restoring intracellular glutathione. Its combination of transcriptomics, pathway validation, metabolic analysis, and protein-turnover experiments provides a framework for connecting sphingolipid synthesis with HIF1α stability and ferroptotic stress responses.
-
Hoechst 33342 for Mechanobiology Imaging
2026-09-16
Hoechst 33342 is more than a nuclear label: it can provide a live-cell map of nuclear position, morphology, and cell-state context in advanced mechanobiology assays. This article explains how to integrate the bis-benzimidazole fluorescent dye with optical-trapping studies of tunneling nanotube cargo transport while controlling spectral, biological, and analytical confounders.
-
Trichostatin A (TSA) Workflow for HDAC Research
2026-09-16
Trichostatin A (TSA) provides a reversible way to connect histone acetylation with cancer-cell phenotypes, differentiation, and regeneration biology. This practical guide covers dose planning, chromatin readouts, axolotl assay design, and troubleshooting for more reproducible HDAC experiments.
-
CB-839 (Telaglenastat): Workflow Guide
2026-09-15
CB-839 (Telaglenastat) provides a reversible, selective way to test whether GLS1-dependent glutaminolysis supports tumor-cell fitness. This workflow connects metabolic inhibition, apoptosis, and autophagy assays with the PRMT5–splicing–metabolism vulnerability reported in MYCN-amplified neuroblastoma.
-
Tariquidar (XR9576) in Viscosity-Driven Resistance
2026-09-15
Tariquidar (XR9576) helps separate P-glycoprotein-mediated efflux from broader mechanical stress responses in tumor-like viscosity models. This guide converts the reference study’s TRPV4–YAP–P-gp mechanism into practical accumulation, chemoresistance, and transporter-mediated drug disposition workflows.
-
Dibutyryl-cAMP, Sodium Salt in Pain Signaling
2026-09-14
Dibutyryl-cAMP, sodium salt is a cell-permeable cAMP analog for testing how cAMP–PKA signaling intersects with neuroinflammation and mechanosensation. This article translates recent trigeminal neuralgia findings into practical assay-design decisions, controls, and interpretation limits.
-
KIR2.1 Inhibition in Pulmonary Vascular Remodeling
2026-09-14
This study identifies KIR2.1 as a functional regulator of pulmonary artery smooth muscle cell proliferation and migration in pulmonary hypertension models. Using monocrotaline-exposed rats and PDGF-BB-stimulated human cells, the authors connect KIR2.1 inhibition with reduced TGF-β1/SMAD2/3 signaling, OPN expression, and PCNA expression, providing a mechanistic framework for pulmonary vascular remodeling research.
-
Tau Ser356, NUAK Inhibition, and Alzheimer’s
2026-09-13
Taylor et al. associate tau phosphorylation at serine 356 with Alzheimer’s disease progression, neurofibrillary tangles, and synaptic localization. Their ex vivo experiments further show that NUAK inhibition lowers p-tau Ser356 in human brain slices, while producing a broader and less selective response in mouse cultures.
-
TCF25, V-ATPase, and Lysosomal Cell Death
2026-09-12
Ren et al. identify TCF25 as a nutrient sensor that connects glucose starvation to V-ATPase-dependent lysosomal acidification, adaptive autophagy, and eventual lysosome-dependent cell death. The study combines a genome-wide CRISPR-Cas9 screen with genetic and in vivo validation, providing a framework for studying how lysosomal function determines whether nutrient stress supports survival or causes tissue injury.
-
Gastric Cancer Assembloids Model Tumor–Stroma Biology
2026-09-11
The 2025 reference study introduces patient-derived gastric cancer assembloids that combine matched tumor organoids with separately expanded stromal cell subpopulations. The model reveals that stromal composition changes tumor-associated gene expression and drug sensitivity, supporting more physiologically relevant studies of resistance and personalized treatment.
-
Trichostatin A (TSA) for HDAC Research
2026-09-11
Trichostatin A (TSA) offers a reversible way to connect histone acetylation with proliferation, differentiation, and combination-treatment response. This practical guide translates its use from breast cancer and chromatin assays to preclinical oncolytic herpesvirus studies, with executable conditions and troubleshooting checkpoints.
-
OSMI-1: O-GlcNAc Transferase Inhibitor Workflow
2026-09-10
OSMI-1 provides a cell-permeable way to reduce O-GlcNAcylation and test OGT-dependent mechanisms in trophoblast, ferroptosis, and organelle-stress models. This practical workflow separates target engagement from cytotoxicity while translating the HUWE1–TfR1 findings into controlled assay decisions.
-
IGFBP2–THBS1 Axis in GH Therapy for ISS
2026-09-10
A 2025 study identifies an IGFBP2–THBS1 regulatory axis that links growth hormone exposure to IGF-1 pathway activity in human chondrocytes relevant to idiopathic short stature. Patient plasma data, interaction prediction, and gain- and loss-of-function experiments indicate that IGFBP2 is a key mediator of chondrocyte proliferation and hypertrophic differentiation, although clinical transferability remains to be established.
-
Macromolecular Cryoprotectants for THP-1 Cells
2026-09-09
A 2025 RSC Applied Polymers study shows that polyampholyte-based cryoprotectants and controlled ice nucleation can improve post-thaw recovery and differentiation of THP-1 monocytes. By combining vial and multi-well preservation with cryo-Raman analysis, the work links reduced intracellular ice formation to more reliable assay-ready immune-cell workflows.